Synthesis and characterization of poly(2-ethyl 2-oxazoline)-conjugates with proteins and drugs: Suitable alternatives to PEG-conjugates?

被引:198
作者
Mero, Anna [2 ]
Pasut, Gianfranco [2 ]
Via, Lisa Dalla [2 ]
Fijten, Martin W. M. [1 ,3 ]
Schubert, Ulrich S. [1 ,3 ,4 ]
Hoogenboom, Richard [1 ,3 ]
Veronese, Francesco M. [2 ]
机构
[1] Eindhoven Univ Technol, Lab Macromol Chem & Nanosci, NL-5600 MB Eindhoven, Netherlands
[2] Univ Padua, Dept Pharmaceut Sci, I-35128 Padua, Italy
[3] Dutch Polymer Inst, NL-5600 MB Eindhoven, Netherlands
[4] Univ Jena, Lab Organ & Macromol Chem, D-07743 Jena, Germany
关键词
poly(2-oxazoline); poly(ethylene glycol); conjugate; trypsin; Ara-C;
D O I
10.1016/j.jconrel.2007.10.010
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Poly(2-ethyl-2-oxazoline) (POZ) was synthesized by living cationic ring-opening polymerization under microwave irradiation yielding polymers with low polydispersity indices (PD1, 1.15). The polymerization was quenched with sodium carbonate yielding a hydroxyl end-group with a high degree of functionality. The hydroxyl group was converted to carboxylate and the polymer was purified by ionic exchange chromatography. Following activation to succinimidyl ester, POZ-conjugates to high and low molecular weight biomolecules, trypsin and Ara-C, were obtained. The properties of the conjugates were compared to those of the corresponding conjugates with poly(ethylene glycol) (PEG) of similar size. The coupling of POZ to trypsin did not affect the enzymatic activity towards low mass substrates but, on the contrary, reduced the activity on the higher mass ones. Furthermore, the POZ-protein conjugates showed hydrodynamic volumes and protein rejecting properties similar to those of PEG-conjugates. Similarly, the POZ-Ara-C conjugate revealed a drug release profile, stability towards the degrading enzyme cytidine deaminase and in vitro cytotoxicity comparable to what has already been described for the PEG derivative. These data support the potential of POZ as a versatile alternative to the well-known and widely used PEG for protein and drug conjugation and delivery. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:87 / 95
页数:9
相关论文
共 36 条
[21]  
LAUER SJ, 1987, CANCER, V60, P2366, DOI 10.1002/1097-0142(19871115)60:10<2366::AID-CNCR2820601003>3.0.CO
[22]  
2-U
[23]   Site-specific PEGylation of hemoglobin at cys-93(β):: Correlation between the colligative properties of the PEGylated protein and the length of the conjugated PEG chain [J].
Manjula, BN ;
Tsai, S ;
Upadhya, R ;
Perumalsamy, K ;
Smith, PK ;
Malavalli, A ;
Vandegriff, K ;
Winslow, RM ;
Intaglietta, M ;
Prabhakaran, M ;
Friedman, JM ;
Acharya, AS .
BIOCONJUGATE CHEMISTRY, 2003, 14 (02) :464-472
[24]  
MARTINEZ AJ, Patent No. 5605976
[25]   PREPARATION AND ENZYMATIC-ACTIVITY OF POLY[(N-ACYLIMINO)ETHYLENE]-MODIFIED CATALASE [J].
MIYAMOTO, M ;
NAKA, K ;
SHIOZAKI, M ;
CHUJO, Y ;
SAEGUSA, T .
MACROMOLECULES, 1990, 23 (13) :3201-3205
[26]   A BRANCHED MONOMETHOXYPOLY(ETHYLENE GLYCOL) FOR PROTEIN MODIFICATION [J].
MONFARDINI, C ;
SCHIAVON, O ;
CALICETI, P ;
MORPURGO, M ;
HARRIS, JM ;
VERONESE, FM .
BIOCONJUGATE CHEMISTRY, 1995, 6 (01) :62-69
[27]   N-hydroxysuccinimide carbonates and carbamates are useful reactive reagents for coupling ligands to lysines on proteins [J].
Morpurgo, M ;
Bayer, EA ;
Wilchek, M .
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, 1999, 38 (01) :17-28
[28]   THE THERAPEUTIC VALUE OF POLY(ETHYLENE GLYCOL)-MODIFIED PROTEINS [J].
NUCCI, ML ;
SHORR, R ;
ABUCHOWSKI, A .
ADVANCED DRUG DELIVERY REVIEWS, 1991, 6 (02) :133-151
[29]  
Onishi H, 1991, Drug Des Deliv, V7, P139
[30]   IMPROVED 2,4,6-TRINITROBENZENESULFONIC ACID METHOD FOR DETERMINATION OF AMINES [J].
SNYDER, SL ;
SOBOCINSKI, PZ .
ANALYTICAL BIOCHEMISTRY, 1975, 64 (01) :284-288